InvestorsHub Logo
Followers 10
Posts 217
Boards Moderated 0
Alias Born 01/24/2020

Re: mick post# 231

Thursday, 07/23/2020 10:03:53 PM

Thursday, July 23, 2020 10:03:53 PM

Post# of 956
A message relayed
“It seems that Steve King and Mateon have been getting some attention lately and when is the PR scheduled for the Covid-19 Clinical trial and CA4P just another surprise pending - as Steve King was collaborating long ago with OXiGene ( name changed to Mateon ) and Oncotelic founders know well of Celgene / Abraxane ties : this all leads quite the run up from .25 and instant $1+ stock. “

OT-101 is also being deployed as anti-COVID-19 agent. The IND for COVID-19 has been submitted and we plan to initiate the clinical trial as soon as possible.
http://investor.mateon.com/news-releases/news-release-details/fda-grants-pediatric-disease-designation-mateons-ca4p

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent OTLC News